The Use of Molecular Pathway Inhibitors in the Treatment of Osteosarcoma
Presently, the 5-year survival rate for metastatic osteosarcoma remains low despite advances in chemotherapeutics and neoadjuvant therapy. A majority of the morbidity and nearly all of the mortality in osteosarcoma rely not in the primary disease but in the metastatic disease. The pursuit of novel m...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Ebooks |
| Published: |
IntechOpen,
2017-04-26.
|
| Subjects: | |
| Online Access: | Get Online |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|